My present work is focused on the development and validation of liposomal vaccine adjuvants. I have worked in malaria transmission-blocking vaccines in collaboration with the PATH Malaria Vaccine Initiative (PATH-MVI) and the Global Health Innovation Technology Fund (GHIT).
I have over seven years of working with liposomes, and over four years of experience in vaccine development, antigen-liposomes conjugation and mice immunization.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
×
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
×
Please sign in or register for FREE
Sign in to Nature Portfolio Bioengineering Community
Register to Nature Portfolio Bioengineering Community
The Nature Portfolio Bioengineering Community is a community blog for readers and authors of Nature Research journals, including Nature Biomedical Engineering, Nature Biotechnology, Nature Communications, Nature Medicine, and others. Become a member, and contribute with research news and stories.